Live feed10:00:00·1289dPRReleasevia QuantisnowKeros Therapeutics Presents Clinical Data from its KER-050 and KER-047 Programs and Preclinical Data from its KER-050 and ALK2 Inhibitor Programs at the 64th American Society of Hematology Annual Meeting and ExpositionByQuantisnow·Wall Street's wire, on your screen.KROS· Keros Therapeutics Inc.Health Care
